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CO2 enhances the formation, nutrient scavenging and drug
resistance properties of C. albicans biofilms
Daniel R. Pentland1, Jack Davis1, Fritz A. Mühlschlegel2 and Campbell W. Gourlay 1✉
C. albicans is the predominant human fungal pathogen and frequently colonises medical devices, such as voice prostheses, as a
biofilm. It is a dimorphic yeast that can switch between yeast and hyphal forms in response to environmental cues, a property that
is essential during biofilm establishment and maturation. One such cue is the elevation of CO2 levels, as observed in exhaled breath
for example. However, despite the clear medical relevance, the effect of CO2 on C. albicans biofilm growth has not been
investigated to date. Here we show that physiologically relevant CO2 elevation enhances each stage of the C. albicans biofilm-
forming process: from attachment through maturation to dispersion. The effects of CO2 are mediated via the Ras/cAMP/PKA
signalling pathway and the central biofilm regulators Efg1, Brg1, Bcr1 and Ndt80. Biofilms grown under elevated CO2 conditions
also exhibit increased azole resistance, increased Sef1-dependent iron scavenging and enhanced glucose uptake to support their
rapid growth. These findings suggest that C. albicans has evolved to utilise the CO2 signal to promote biofilm formation within the
host. We investigate the possibility of targeting CO2-activated processes and propose 2-deoxyglucose as a drug that may be
repurposed to prevent C. albicans biofilm formation on medical airway management implants. We thus characterise the
mechanisms by which CO2 promotes C. albicans biofilm formation and suggest new approaches for future preventative strategies.
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INTRODUCTION
Candida albicans is a commensal yeast located on the mucosal
surfaces of the oral cavity, gastrointestinal tract and genitourinary
tract of most healthy individuals1,2. Despite being a commensal
organism, it is also an opportunistic pathogen1,3; in fact, it is the
most widespread of all the human fungal pathogens4 and is the
fourth most common cause of hospital-acquired infections in the
USA1. Infection with C. albicans is a particular problem among
immunocompromised individuals or persons with implanted
medical devices such as catheters or voice prostheses (VPs)5,6
upon on which the yeast grows as a biofilm7.
Biofilms are structured communities of microorganisms
attached to a surface. The cells are often encased within an
extracellular matrix (ECM), which is commonly comprised of
DNA8,9, lipids8, proteins8,10 and polysaccharides8. C. albicans is able
to form biofilms on both abiotic and biotic surfaces and biofilm-
associated cells are considerably more resistant to traditional
antifungals when compared to planktonic cells11. The reasons for
this increased resistance are complex but include the presence of
an ECM that can act as a barrier to prevent antimicrobial agents
reaching the cells12,13, the presence of metabolically dormant
persister cells inherent to biofilms14 and the upregulation of drug
efflux pumps15. A significant percentage of human microbial
infections arise from or are mediated via the formation of a
biofilm16–18, and this, combined with the limited treatment
options available, means the ability of C. albicans to grow as a
biofilm is of particular medical interest.
C. albicans is a dimorphic fungus, and it has the ability to
undergo a morphogenic switch from a yeast to pseudohyphal or
hyphal forms in response to environmental cues. The virulence of
C. albicans is closely linked with the capacity to switch between
these forms: hyphal C. albicans cells are frequently located at sites
of tissue invasion, and cells that are unable to readily form hyphae
exhibit reduced virulence1. The yeast-to-hyphal switch is also
critical to biofilm formation as hyphal cells express a number of
specific cell surface adhesins that enable cell–cell and cell–surface
attachment19.
C. albicans biofilm formation is a complex process involving
tightly regulated, interwoven signalling pathways centrally con-
trolled by a set of nine transcription factors (TFs): Bcr1, Brg1, Efg1,
Flo8, Gal4, Ndt80, Rob1, Rfx2, and Tec120,21. These nine essential
regulators function at different stages throughout C. albicans
biofilm formation22 and coordinate the expression of >1000 target
genes upregulated during biofilm formation20. Please see Lohse
et al.23 for a comprehensive review of C. albicans biofilms.
Elevated CO2 levels, as found in a number physiologically
relevant scenarios such as in exhaled breath or hypercapnia, have
been shown to promote the yeast-to-hyphal switch in C. albicans.
CO2 is converted to bicarbonate ions HCO3− by the enzyme
carbonic anhydrase, which in turn activate the adenylate cyclase
Cyr1, resulting in increased cAMP levels and the protein kinase A
(PKA)-dependent activation of hyphal specific genes24. The yeast-
to-hyphal switch is critical to the biofilm maturation process of C.
albicans25, as well as being important to its virulence1. The effect
of CO2 may be particularly important within the context of biofilm
development on VPs or other airway management devices as they
are situated in the throat of patients where they are consistently
exposed to high CO2 (5%) levels during exhalation. If CO2 does
play a role in C. albicans biofilm maturation, it could offer a
possible explanation as to why C. albicans is found in such high
frequencies on failed VPs. In addition, CO2 content within the
blood is also elevated (46 and 40mmHg for venous and arterial
blood, respectively, vs. 0.3 mmHg found in atmospheric air)26,27,
and it has been estimated that as many as 80% of all microbial
infections directly or indirectly involve pathogenic biofilms28.
Thus, the work presented here could be more widely applicable to
bloodstream infections and biofilm formation within the body.
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Here we demonstrate that physiologically relevant increases in
CO2 accelerate C. albicans biofilm formation on silicone surfaces.
Transcriptome analysis reveals that several core biofilm regulatory
pathways, including those governed by Efg1, Bcr1, Brg1 and
Ndt80, are upregulated. We also demonstrate that a high CO2
environment results in increased resistance of biofilms to azole
antifungals, enhanced dispersal of cells from mature biofilms and
an increase in capacity for glucose uptake. Moreover, a transcrip-
tion factor knockout (TFKO) library screen demonstrated TFs
involved in the acquisition of iron, such as the HAP TFs Hap43,
Hap2, Hap3 and Hap5, to be important for C. albicans biofilm
formation on silicone surfaces in atmospheric CO2 conditions.
However, high CO2 was able to overcome the requirement for
HAP TF activity and enable C. albicans biofilms to forage for
essential metabolites to support growth. Overall, we propose that
C. albicans has adapted to utilise the high CO2 environment found
in the host to promote its ability to colonise and to compete for
nutrition. Our analysis reveals new approaches that can be taken
to prevent C. albicans biofilm formation in high CO2 environments
that pave the way for new therapeutic approaches to treat these
highly drug-resistant structures.
RESULTS
CO2 enhances C. albicans biofilm growth
C. albicans biofilms were seeded and grown on silicone in CO2
levels found in exhaled air (5%) and atmospheric air (0.03%) for 24
and 48 h. Biofilms were quantified using the XTT assay, which is a
metabolic dye that acts as a readout of viable cell number29. After
24 h of growth, both CAI4pSM2 and SN250 C. albicans strains
exhibited a significantly higher absorbance at 492 nm for biofilms
grown in a 5% CO2. However, after 48 h, biofilms grown in both
CO2 conditions had equivalent 492 nm absorbance (Fig. 1a).
Interestingly, although XTT readout appeared comparable at 48 h,
the resultant biofilm mass was noticeably larger in biofilms grown
under elevated CO2 conditions (Fig. 1b). We quantified this larger
biofilm mass via confocal scanning laser microscopy (CSLM) and
dry biomass assays. CSLM showed a significantly increased biofilm
thickness when grown in 5% CO2 at both 24 and 48 h growth (Fig.
1c). Unlike cell number, the overall biofilm thickness did not
increase between 24 and 48 h in either CO2 environment (Fig. 1c).
However, the dry biomass of SN250 biofilms grown in 5% CO2 was
significantly higher compared to those grown in 0.03% CO2 at
both 24 and 48 h growth (Fig. 1d). Importantly, these increases in
growth appear to be a biofilm-specific phenomenon, and not
simply a result of increased growth rate in elevated CO2
conditions, as planktonic growth assays showed no significant
difference between C. albicans generation time in 0.03 and 5%
CO2 environments (Supplementary Fig. S1).
Analysis of the effects of CO2 on phases of C. albicans biofilm
growth
We sought to determine which phases of biofilm growth were
influenced by CO2 elevation. To investigate the attachment phase
C. albicans cells were seeded for 90min onto silicone-coated
microscopic slides under 0.03% CO2 or 5% CO2 levels. We
observed that exposure to elevated CO2 led to a significant
increase in the number of cells that attached to silicone (mean of
2108 cells in 0.03% vs. mean of 7033 cells in 5% CO2) (Fig. 2a). Cells
also appeared to attach as larger aggregations in 5% CO2 when
compared to those in 0.03% CO2 (Supplementary Figs. S2A, B)
indicating that both cell–substrate and cell–cell attachments may
be enhanced. These cell aggregations were not the consequence
of cell wall stress. C. albicans exhibited equivalent sensitivities to
the cell wall stressors Congo Red and Calcofluor White in both
atmospheric and 5% CO2 environments (Supplementary Fig. S3A),
with no statistically significant difference in lag time duration or
generation time at each stressor concentration in a planktonic
growth assay (Supplementary Fig. S3B).
CSLM was used to investigate the effects of CO2 on biofilm
growth during maturation. C. albicans biofilms were seeded on
silicone-coated microscopic slides and images were taken at 6, 24
and 48 h of growth under either 0.03% or 5% CO2 growth
conditions (Fig. 2b). Biofilm images are displayed as maximum
intensity ortho-projections of Z-stacks to give a view of the overall
structures of the biofilms. After 6 h growth in 0.03% CO2, the
majority of cells were found in the yeast form with some visibly
initiating hyphae. In comparison, biofilms grown in 5% CO2
appeared to consist of a high proportion of hyphal cells, were
visibly denser and had begun to exhibit an ordered structure in
the Z-plane (Fig. 2b). After 24 h growth in 0.03% CO2, biofilms
were progressing through the maturation stage with the
appearance of numerous hyphal cells. However, the 5% CO2
biofilms exhibited a fully mature biofilm organisation displaying
hyphal cells organised in a brush-like structure above a basal layer
of yeast cells (Fig. 2b). At 48 h, biofilms grown in both 0.03% and
5% CO2 appeared as dense mature structures; however, biofilms
grown under elevated CO2 appeared larger (Fig. 2b) as had been
observed previously (Fig. 1b, c).
Dispersion is the final stage of biofilm formation, we therefore
investigated whether CO2 elevation resulted in increased levels of
cell shedding. We routinely observed that spent RPMI-1640 media
isolated after biofilm growth in 5% CO2 contained more cells than
that of taken from biofilms grown in 0.03% CO2 (Supplementary
Fig. S3A). We quantified this by seeding and growing C. albicans
biofilms for 48 h in 0.03% and 5% CO2 and conducting colony-
forming unit assays using the spent RPMI-1640 media (Fig. 2c and
Supplementary Fig. S4B). Our results showed an approximate
fourfold increase in cell number released from mature biofilms
when grown under elevated CO2 conditions, consistent with an
increase in dispersal. Overall, these data demonstrate that the
elevation of CO2 enhances each stage of the C. albicans biofilm-
forming process, from attachment through maturation to
dispersion.
Identification of the regulatory mechanisms that govern CO2
acceleration of C. albicans biofilm formation
In planktonic C. albicans cells, CO2 is converted to bicarbonate ions
(HCO3−), which stimulates the adenylate cyclase Cyr1 (Cdc35),
causing an increase in cAMP and activation of PKA24. We
investigated whether CO2 elevation may drive biofilm formation
and maturation via a similar Ras/cAMP/PKA mechanism. We
conducted biofilm growth assays using C. albicansmutants lacking
key components of the pathway: ras1Δ/Δ, cdc35Δ/Δ, CDC35ΔRA
(adenylate cyclase missing the Ras1 interacting domain), tpk1Δ/Δ
(missing a catalytic subunit isoform of PKA), and tpk2Δ/Δ (missing
the other catalytic subunit isoform of PKA). Biofilm formation was
quantified after 48 h of growth and compared to an isogenic wild-
type control. The ras1Δ/Δ mutant displayed significantly attenu-
ated biofilm growth in 0.03% CO2 but this was rescued to wild-
type levels in 5% CO2 (Fig. 3a), indicating that Ras1 function is
dispensable for biofilm formation under conditions of elevated
CO2. The cdc35Δ/Δ and CDC35ΔRA mutants both exhibited
significantly reduced biofilm growth when grown under either
atmospheric or elevated CO2 conditions (Fig. 3a). Both tpk1Δ/Δ
and tpk2Δ/Δ mutants exhibited biofilm growth equivalent to the
wild type under both CO2 conditions (Fig. 3a). To further explore
the ras1Δ/Δ and cdc35Δ/Δ biofilm phenotypes, we conducted
silicone surface attachment assays. Contrary to the biofilm growth
assays, attachment of both mutants was similar to the wild type in
0.03% CO2 (Fig. 3b). Significantly fewer cdc35Δ/Δ cells than wild
type attached to silicone in 5% CO2, interestingly, despite its wild-
type levels of biofilm formation in 5% CO2; this was also the case
for the ras1Δ/Δ mutant (Fig. 3b). Taken together, this data implies
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that both Ras1 and Cyr1 are required for CO2-mediated
attachment increase, while the CO2 effect on C. albicans biofilm
growth is reliant on Cyr1 but can bypass a requirement for Ras1.
Moreover, under these experimental conditions, the PKA isoforms
Tpk1 and Tpk2 are functionally redundant with respect to cAMP
activation of the biofilm programme; however, we are not able to
discount the possibility that Cyr1 may direct biofilm formation
independently of PKA activation. Our findings are consistent with
the adenylate cyclase Cyr1 as a key CO2 sensor in the enhanced
biofilm growth observed under elevated CO2 conditions.
To investigate the molecular basis of the activation of C.
albicans biofilm formation in 5% CO2, we conducted a screen of an
available TFKO library30 containing 147 mutants each lacking a
non-essential TF. This screen identified 122 deletions that had no
effect upon biofilm formation in either CO2 condition (Supple-
mentary Fig. S5) and 22 TFs, which attenuated biofilm formation
(Supplementary Table S2). Six TFKO mutants (tup1Δ/Δ, sef1Δ/Δ,
swi4Δ/Δ, pho4Δ/Δ, bcr1Δ/Δ and efg1Δ/Δ) had diminished biofilm
growth in both 0.03% and 5% CO2, 12 had reduced biofilm
formation only in 0.03% CO2 (hap2Δ/Δ, rbf1Δ/Δ, rob1Δ/Δ, fgr15Δ/Δ,
dal81Δ/Δ, mig1Δ/Δ, brg1Δ/Δ, C4_00260WΔ/Δ, zcf27Δ/Δ,
C1_13880CΔ/Δ, crz1Δ/Δ and hap43Δ/Δ), and 4 TFKOs had reduced
biofilm formation only in 5% CO2 (leu3Δ/Δ, mbp1Δ/Δ, bas1Δ/Δ and
try6Δ/Δ) (Supplementary Table S2 and Supplementary Fig. S5).
Intriguingly, 3 additional mutants, zcf17Δ/Δ, zcf30Δ/Δ and mac1Δ/
Δ, displayed increased biofilm growth in 0.03% CO2 but no
significant difference in 5% CO2.
We performed gene ontology (GO) enrichment analysis on the
genes encoding the 25 TFs whose loss impacted upon biofilm
growth to group them according to biological processes. This
revealed that seven of these TFs—Brg1, Bcr1, Efg1, Rob1, Dal81,
Leu3 and Try6—were already known to be involved in the
regulation of single-species biofilm formation within C. albicans
(Supplementary Table S2). Interestingly, out of these, only the
efg1Δ/Δ and bcr1Δ/Δ mutant exhibited attenuated biofilm growth
in both 0.03% and 5% CO2. The brg1Δ/Δ, dal81Δ/Δ and rob1Δ/Δ
mutants had significantly reduced biofilm growth in 0.03% CO2,
but this was rescued in the 5% CO2 environment (Supplementary
Table S2), possibly indicating redundancy of these TFs when cells
are exposed to high CO2. This important finding suggests that CO2
elevation can bypass the requirement for some of the key
transcriptional regulators of biofilm formation (Fig. 3c). The leu3Δ/
Δ and try6Δ/Δmutants had significantly reduced biofilm growth in
5% CO2 but no significant difference in 0.03% CO2. Eight of the TFs
identified—Brg1, Crz1, Efg1, Mac1, Mig1, Rob1, Zcf27, Zcf30—are
associated with the positive regulation of filamentous growth and
Tup1 is involved in the negative regulation of filamentous growth.
C. albicans biofilm formation is strongly linked with the yeast-to-
hyphal switch, with mutants unable to perform this switch having
previously been shown to be deficient in biofilm growth 25.
Regulation of iron homoeostasis in C. albicans biofilms
The TFKO screen also revealed that mutants lacking TFs associated
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Fig. 1 The effect of high CO2 (5%) on C. albicans biofilm formation. a Reference strain biofilms were seeded and grown for 24 or 48 h in
0.03% or 5% CO2; the resulting biofilms were quantified using the XTT assay with absorbance at 492 nm as a readout. b Representative images
of C. albicans (SN250 strain) biofilms grown in 0.03% and 5% CO2 for 48 h (red colouration due to XTT assay). c SN250 biofilms were seeded on
chamber slides and grown for 24 or 48 h in 0.03% or 5% CO2 before staining with SPYRO Ruby biofilm matrix stain. Z-stacks were taken using
×20 objective magnification and biofilm thickness was quantified. Graphs represent three biological replicates, error bars denote standard
deviation. Paired two-tail t tests were carried out: ***p < 0.001, n.s.= not significant.
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altered biofilm formation in 0.03% and/or 5% CO2 (Fig. 4a and
Supplementary Table S2). Mutants lacking genes expressing
components of the HAP complex: hap2Δ/Δ, hap3Δ/Δ, hap5Δ/Δ
and hap43Δ/Δ, exhibited significantly reduced biofilm growth
after 48 h compared to wild type in 0.03% CO2. However, their
biofilm growth was significantly higher in 5% CO2, reaching wild-
type levels in the cases of the hap3Δ/Δ, hap5Δ/Δ and hap43Δ/Δ
mutants (Fig. 4a). This is an important observation as it indicates
that an increase in CO2 concentration is sufficient to compensate
for the loss of these TFs. The HAP complex in C. albicans is
responsible for the regulation of iron homoeostasis31. Sef1 acts
downstream of this complex as an activator of iron uptake genes
and the sef1Δ/Δ mutant displayed significantly reduced biofilm





















Fig. 2 The effects of CO2 on C. albicans biofilm growth. a Attachment: C. albicans CAI-4 cells were seeded onto silicone-coated microscope
slides under 0.03% or 5% CO2 and images were taken at ×20 objective magnification. Cells per image were counted and the mean was
calculated across three biological replicates (five images per replicate). A paired two-tail t test was carried out: **p < 0.01. Error bars denote
standard deviation. b Maturation: Biofilms were seeded on silicone-coated microscope slide and grown for 6, 24 and 48 h. Biofilms were
stained with ConA-FITC (green) and FUN-1 (red). Z-stack images were taken using ×20 (6 h) and ×40 (24 and 48 h) magnifications. Experiments
were repeated in triplicate and representative maximum intensity images are presented as well as Z-stack profiles. c Dispersion: Spent media
was collected from biofilms grown for 48 h in 0.03% or 5% CO2 and diluted 1:10 before being plated to assess the number of colonies. Three
biological replicates each containing technical triplicates were conducted, error bars denote standard deviation. A paired two-tail t test was
carried out: *p < 0.05.
D.R. Pentland et al.
4
npj Biofilms and Microbiomes (2021)    67 Published in partnership with Nanyang Technological University
transcriptional repressor Sfu1 and the kinase Ssn3 are negative
and positive regulators of Sef1 activity, respectively32; the sfu1Δ/Δ
mutant showed significantly increased biofilm growth compared
to wild type in both CO2 environments, while the ssn3Δ/Δ mutant
presented an identical phenotype to sef1Δ/Δ (Fig. 4a). These data
suggest that the elevation of CO2 can bypass the requirement for
HAP complex activity in biofilm formation in a Sef1-dependent
manner.
Intriguingly, in attachment assays on a silicone surface, none of
these iron homoeostatic mutants showed a statistically significant
difference in attachment compared to wild type in 0.03% CO2 (Fig.
4b). However, the sfu1Δ/Δ, ssn3Δ/Δ, sef1Δ/Δ, hap2Δ/Δ and hap3Δ/Δ
mutants all attached in significantly lower numbers than wild type
in 5% CO2, suggesting a role for iron homoeostatic control in the
CO2-dependent attachment increase. Furthermore, unlike mature
biofilm quantification, none of the HAP complex mutants
displayed a CO2-dependent attachment phenotype (Fig. 4b).
Immunoblot analysis of Myc-tagged Sef1 recovered from 48 h
biofilms in wild-type, sfu1Δ/Δ and ssn3Δ/Δ backgrounds revealed that
Sef1 levels were higher in wild-type mature biofilms grown in 5%
CO2 than those grown in atmospheric CO2 (Fig. 4c, lanes 1 and 2).
Sef1 was present in mature biofilms regardless of environmental CO2
levels in the absence of Sfu1 (Fig. 4c, lanes 3 and 4). However, in the
absence of Ssn3, Sef1 expression was low in either CO2 condition
(Fig. 4c). These data are not only consistent with Sfu1 and Ssn3 being
negative and positive regulators, respectively, of Sef1, as demon-
strated in planktonic cells by Chen et al.32, but also suggest a role for
a CO2 in activating iron uptake pathways in C. albicans biofilms in an
Ssn3-dependent manner.
To further determine whether elevated CO2 enhanced C.
albicans ability to appropriate iron from the environment, biofilms
were grown in the presence of the Fe2+ chelator Ferrozine. Iron
chelation was observed to have a marked effect on biofilm growth
at and above 350 μM Ferrozine in RPMI media (Fig. 5a). As had
been observed with TFKO strains of the HAP complex, the
elevation of CO2 counteracted the effects of iron limitation (Fig.
5a), providing further evidence of a role for CO2 in enhancing iron
uptake or utilisation capability. This tolerance to iron starvation of
C. albicans biofilms grown in 5% CO2 was also exhibited by tpk1Δ/
Δ and tpk2Δ/Δ mutants (Supplementary Fig. S5), indicating that
these PKA isoforms are functionally redundant with respect to iron
homoeostatic pathways. Clinical strains of C. albicans isolated from
failed VPs displayed the same phenotype with biofilm formation
rescued in 5% CO2 when grown in the presence of 500 μM
Ferrozine (Fig. 5b). A transcriptomic analysis comparing biofilms
grown in 0.03% and 5% CO2 (described below) revealed that


























































Fig. 3 Biofilm growth assays of C. albicans Ras1-Cyr1-PKA pathway and central biofilm regulator null mutants. Cells were seeded and
counted or grown as biofilms for 48 h before XTT quantification. a Biofilm growth assay using Ras1-Cyr1(Cdc35)-PKA pathway null mutants.
b Attachment assay on silicone surface using ras1Δ/Δ and cdc35Δ/Δ mutants. c Biofilm growth assay using central biofilm regulator null
mutants. Graphs represent three biological replicates, error bars denote standard deviation. Two-way ANOVAs followed by Tukey tests for
multiple comparisons were carried out: *p < 0.05, **p < 0.01, ***p < 0.001. Asterisks directly above the bars indicate a significant difference to
the wild type in the same CO2 environment.
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CO2 biofilms, providing an explanation for the tolerance to iron
sequestration in high CO2.
Transcriptome analysis of C. albicans biofilms grown in high
and low CO2
To further investigate the effect of high CO2 on C. albicans biofilm
growth, we performed an RNA Sequencing (RNA-Seq) analysis of
C. albicans biofilms grown in 0.03% and 5% CO2. Growth in 5%
CO2 led to a global response resulting in the significant differential
expression (false discovery rate (FDR) adjusted p value (q) ≤0.05) of
2875 genes, with roughly equal numbers of genes upregulated
and downregulated (1441 up and 1434 down) (Supplementary
Fig. S7A). Eighty genes were strongly (log2 fold change >2)
upregulated and 25 were strongly (log2 fold change <−2)
downregulated. To investigate the cellular pathways which these
differentially expressed genes are within, we conducted Gene Set
Enrichment Analysis (GSEA; Broad Institute)33. GSEA revealed that
biofilm formation pathways controlled by four of the nine ‘core’
biofilm regulator TFs20,21 were upregulated in 5% CO2 biofilms at
48 h (Fig. 6a). Genes downstream of Brg1, Efg1, Ndt80 and Bcr1 are
enriched in the upregulated genes at the top of the ranked list of
differentially expressed genes (normalised enrichment score (NES)
=+2.79, +2.66, +2.56 and +2.60, respectively; Fig. 6a), indicating
that high CO2 drives the expression of genes previously described
as important in the biofilm-forming ability of C. albicans.
As GSEA can show enrichment profiles exhibiting correlations
with several overlapping gene sets, we visualised networks of
similar gene sets using the Cytoscape 3.7.1 EnrichmentMap plug-
in34. Upregulated gene sets included those encoding membrane
transporters, ribosome biogenesis, peroxisomal β-oxidation and
white-opaque switching (Fig. 6b). Pathways involved in cytoske-
leton organisation, cell-cycle progression and membrane bio-
synthesis were downregulated in high CO2 conditions (Fig. 6b),
indicating that cells within biofilms in high CO2 may have stopped
dividing at the 48 h time point assessed, consistent with such
biofilms having moved more rapidly through the maturation
process.
GSEA suggested that cell adhesion processes were upregulated
in high CO2 biofilms (NES=+2.13; Fig. 7a). GO Slim process
analysis also highlighted that many genes associated with cell
adhesion were upregulated in C. albicans biofilms grown in 5%
CO2 after 48 h (Fig. 7b). The second highest upregulated gene in
5% CO2 biofilms compared to 0.03% CO2 biofilms was ALS1 with a
3.77 log2 fold change (Fig. 7b). The Als1 cell surface adhesin has
previously been shown to have important roles in biofilm
formation35, and its expression is controlled by the biofilm
transcription regulation network composed of Brg1, Rob1, Tec1,
Ndt80, Bcr1 and Efg120. Other genes encoding cell surface
adhesins such as ALS4 and ALS2 were also upregulated in 5%
CO2 biofilms after 48 h (Fig. 7b).
GSEA has also identified that genes involved in membrane
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Fig. 4 The effect of high (5%) CO2 on iron homoeostasis in C.
albicans biofilms. a Biofilm growth assay using iron homoeostatic
pathway null mutants. Biofilms were seeded and grown for 48 h
before XTT quantification. b Iron homoeostatic mutants were
seeded on a silicone surface and the number of attached cells
were quantified from microscopic images. Graphs represent at least
three biological replicates each containing technical triplicates, error
bars denote standard deviation. Two-way ANOVAs followed by
Tukey tests for multiple comparisons were carried out: *p < 0.05, **p
< 0.01, ***p < 0.001. c Immunoblot of Sef-Myc and PGK1 (internal











































Fig. 5 The effect of high (5%) CO2 on iron starvation in C. albicans
biofilms. Biofilms were seeded and grown for 48 h in the presence
of the Fe2+ chelator Ferrozine before XTT quantification. a Iron
starvation biofilm growth assay using the SN250 reference strain.
Graph represents six biological replicates each containing technical
triplicates, error bars denote standard deviation. b Iron starvation
biofilm growth assay using clinical isolates. Graph represents three
biological replicates each containing technical triplicates, error bars
denote standard deviation. Two-way ANOVAs followed by Tukey
tests for multiple comparisons were carried out: *p < 0.05, **p < 0.01,
***p < 0.001.
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top of the ranked list of differentially expressed genes (NES=
+2.22; Fig. 7a). Specifically, genes encoding amino acid transpor-
ters were enriched in the significantly upregulated genes of 5%
CO2 biofilms (NES=+2.62). Likewise, significantly differentially
expressed genes possessing the GO term ‘amino acid transport’
were primarily upregulated (Fig. 7b). The most highly upregulated
of these was GAP2, which encodes a general amino acid
permease36. GAP2 was in fact the highest upregulated gene of
the entire RNA-Seq data set with a 4.60 log2 fold change. The
basic amino acid permease genes CAN1, CAN2 and CAN3 were also
upregulated (Fig. 7b).
Genes associated with carbohydrate transmembrane transport
were also enriched in the significantly upregulated genes of 5%
CO2 biofilms as revealed by GSEA (NES=+1.88). Among these
were 12 genes encoding putative major facilitator superfamily
glucose transmembrane transporters present in the significantly
differentially expressed gene list and these were almost all
upregulated. The only exceptions were HGT9 and HGT18 with log2
fold changes of −1.24 and −1.70, respectively (Fig. 7b).
Genes previously identified to be involved in hyphal formation
in response to foetal bovine serum exposure or 37 °C were
enriched in the downregulated genes (NES=−3.41; Supplemen-
tary Fig. S7C). Likewise, the majority of genes under the GO term
‘hyphal growth’ in the significantly differentially expressed gene
list were downregulated in 5% CO2 biofilms at 48 h growth
(Supplementary Fig. S7B). Significantly differentially expressed
genes associated with the cytoskeleton, as identified by GO term
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Fig. 6 Global gene expression changes in 5% CO2 vs. 0.03% CO2 C. albicans biofilms. a GSEA enrichment plots of central biofilm regulator
gene sets with altered expression levels as assessed by RNA Sequencing; four of the nine identified core regulators of biofilm formation (Brg1,
Efg1, Ndt80, and Bcr1)20 were identified as having positive GSEA scores. Vertical black lines represent individual genes in the significantly
differentially expressed ranked gene list from upregulated (left) to downregulated (right). The enrichment score increases if there are lots of
genes towards the beginning of the ranked list (upregulated). NES normalised enrichment score; positive NES indicates enrichment in the
upregulated group of genes. b Gene set cluster map showing the most upregulated and downregulated gene sets as determined by GSEA
along with their cellular functions. Each circle is a gene set and the lines between them depict how much they overlap, thicker line=more
genes in common.
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Supplementary Fig. S7C). Cytoskeleton reorganisation is important
for the growth of C. albicans hyphal cells37 as well as cell
division38,39, indicating that cell growth is lower in 48 h-old C.
albicans biofilms grown in 5% CO2 than in those grown in 0.03%
CO2. Consistent with this, genes involved in the transition through
the G1/S checkpoint were also enriched in the significantly
downregulated genes (NES=−2.83; Supplementary Fig. S7C).
Initially, these data appear to be contradictory to the previous
data highlighting the increased biofilm formation of C. albicans
under high CO2 conditions. However, due to the increased biofilm
formation in a 5% CO2 environment, C. albicans biofilms reach full
maturity much quicker in high CO2, as observed via confocal
microscopy (Fig. 2b). Thus, by 48 h C. albicans biofilms grown in
high CO2 have been fully mature for several hours and hence
would contain fewer dividing cells or cells extending hyphae in
comparison to low CO2 biofilms.
CO2 elevation enhances azole resistance in C. albicans biofilms
In addition to the observed increase in the expression of genes
that drive biofilm formation, we observed an elevation in certain
stress response pathways in C. albicans biofilms grown in 5% CO2.
Gene sets involved in the response of C. albicans to antifungals
such as Ketoconazole40 were predicted to be upregulated (Fig. 8a;
NES=+2.11) as well as several drug transporters (Fig. 8b),
indicating that elevation may lead to increased drug resistance.
Upregulated genes included the MDR1 gene (2.56 log2 fold
change), which encodes the multidrug-resistance pump Mdr1 and
is associated with resistance to several antifungals, such as
azoles41. To test the significance of this, C. albicans biofilms were
seeded and grown for 24 h in 0.03 and 5% CO2 before the addition
of antifungals, after which they were grown for an additional 24 h
in both conditions to observe the effect of drug application.
Antifungal concentrations were selected based upon previously
Fig. 7 Adhesion and transport processes are upregulated in 5% CO2 C. albicans biofilms. a GSEA enrichment plot of the BIOLOGICAL
ADHESION_BIO and TRANSPORTER ACTIVITY_MOL, AMINO ACID TRANSPORT_BIO and CARBOHYDRATE TRANSPORTER ACTIVITY_MOL gene
sets containing genes under the GO terms ‘transporter activity’ and ‘amino acid transport’. NES normalised enrichment score; positive NES
indicates enrichment in the upregulated group of genes. b Heat map of significantly differentially expressed genes associated with cell
adhesion, amino acid transport and glucose transport as identified by GO Slim process analysis. The colours saturate at log2 fold change of 2
and −2.
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reported MIC values for these antifungals against C. albicans
biofilms42. Overall, Fluconazole and Miconazole treatment led to a
significant reduction in biofilm growth in 0.03% CO2 (Fig. 8c and
Supplementary Fig. S8). Treatment with Fluconazole and Micona-
zole also significantly reduced biofilm formation in 5% CO2;
however, their effects were markedly reduced (Fig. 8c and
Supplementary Fig. S8). This suggests an increased resistance of
biofilms grown in 5% CO2 to azole treatment. Interestingly,
Nystatin and Caspofungin were equally as effective against
biofilms in either CO2 environment (Fig. 8d and Supplementary
Fig. S9).
Precision approaches to overcome CO2 acceleration of C.
albicans biofilm formation
Our data indicate that elevation of CO2 leads to an increase in the
ability to scavenge for iron and glucose, both essential for biofilm
formation and growth. We therefore wished to test whether these
represented potential targets to combat C. albicans growth in high
CO2 environments, such as the airway. An Fe3+ chelator called
Deferasirox, which is approved for treating patients with iron
overload, has recently been shown to reduce infection levels in a
murine oropharyngeal candidiasis model43. With this in mind, we
repeated our previous iron starvation biofilm growth assay (Fig.
5a) using Deferasirox in place of Ferrozine. We observed that
Deferasirox treatment completely eradicates C. albicans biofilm
growth in 0.03% CO2 but has very little effect on biofilm growth in
5% CO2 (Fig. 9a), thus adding further evidence that exposure to
high levels of CO2 can enable C. albicans biofilms to overcome the
effects of iron starvation. Deferasirox does not therefore appear to
be an effective treatment against C. albicans biofilms in high CO2
such as in the context of VP colonisation.
C. albicans biofilms grown in 5% CO2 exhibited the upregulation
of genes encoding glucose transporters. Accordingly, we con-
templated whether treatment of C. albicans biofilms with the
glucose analogue 2-deoxyglucose (2-DG; a glycolytic inhibitor)
may decrease biofilm growth in high CO2 environments. 2-DG has
previously made it to stage II clinical trials as an anti-prostate
cancer treatment and is considered safe for use in humans44. Thus,
it could be a potential therapeutic option to combat C. albicans
biofilm formation on medical devices, specifically on VPs. C.
albicans biofilm formation was significantly reduced in the
presence of 2-DG regardless of CO2 environment (Fig. 9b and








Fig. 8 Antifungal sensitivity of C. albicans biofilms grown in high (5%) CO2. a GSEA enrichment plot of the KETOCONAZOLE_UP gene set
containing genes upregulated in C. albicans cells grown in the presence of Ketoconazole62. NES normalised enrichment score; positive NES
indicates enrichment in the upregulated group of genes. b Heat map of genes associated with drug transport, including the multidrug efflux
pump gene MDR1. c Biofilm growth assay of CAI4pSM2 in the presence of Fluconazole. d Biofilm growth assay of CAI4pSM2 in the presence of
Nystatin. The relative XTT activity is presented with the 0.03% CO2 biofilms being normalised to the 0.03% CO2 untreated control and the 5%
CO2 biofilms being normalised to the 5% CO2 untreated control. Two-way ANOVAs followed by Tukey tests for multiple comparisons were
carried out: *p < 0.05, **p < 0.01, ***p < 0.001. Asterisks directly above the bars indicate a significant difference to untreated in the same CO2
environment.
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2-DG concentrations were similar for biofilms in both low and high
CO2, despite the fact that several glucose transporters were
upregulated in 5% CO2 biofilms (Fig. 7b). The reduction in biofilm
growth upon 2-DG treatment was also quite apparent macro-
scopically (Fig. 9c).
DISCUSSION
Our data demonstrate for the first time that a physiologically
relevant elevation of CO2 accelerates biofilm formation in C.
albicans by activating the cAMP/PKA pathway (Fig. 10). Interest-
ingly, although CO2 elevation is dependent on Cyr1 it appears to
bypass a requirement for Ras1. CO2 elevation enhances each stage
of the C. albicans biofilm-forming process, from attachment
through maturation to dispersion. The observed increase in cell
attachment is accompanied by an increase in the abundance of
mRNA transcripts for ALS1, ALS2 and ALS4, which encode adhesins
of the agglutinin-like sequence family that function in the
cell–surface and cell–cell attachment of C. albicans19. Our
observed increase in dispersion also correlates with an upregula-
tion of the known regulator of this stage of biofilm growth,
NRG145. However, it cannot be ruled out that this is a consequence
of increased biomass under elevated CO2 and further investigation
to look for lateral yeast budding from hyphae should be carried
out to confirm dispersion. Our observations have important
clinical implication in scenarios where prosthetic devices are
placed in areas of elevated CO2, for example, VPs or tracheostomy
tubing. We would anticipate that high CO2 may increase the
probability of C. albicans colonisation and dissemination.
Of the original six ‘core’ biofilm regulators (Efg1, Bcr1, Brg1,
Rob1, Ndt80 and Tec1), only four (Efg1, Bcr1, Brg1 and Rob1) were
identified as required for normal biofilm growth in our TFKO
screen. The original TFKO screen that identified these regulators
was carried out using a polystyrene surface20, whereas we used
silicone. This may suggest that attachment to and biofilm growth
on silicone requires a more limited set of core TFs reflecting the
importance of surface upon biofilm formation as has been
observed previously21. In support of the environment being
critical to biofilm establishment, CO2 elevation was able to
compensate for the loss of the core biofilm regulators Brg1 and
Rob1. Intriguingly, of the four biofilm regulators whose gene sets
were predicted to be upregulated in 5% CO2 biofilms, Efg1, Bcr1
and Brg1 were identified in our TFKO screen, whereas Ndt80 was
not. Moreover, only efg1Δ/Δ and bcr1Δ/Δ had reduced biofilm
growth in both 0.03 and 5% CO2. This disparity may be explained
by the degree of overlap in downstream target genes between
the core regulators of biofilm formation20, which implies
significant potential for functional redundancy.
Many of the genes significantly upregulated in biofilms grown
in high CO2 after 48 h were also found to be upregulated in other
biofilm gene expression studies46,47. For instance, Nett et al.
observed an increase in the expression of adherence genes in an
in vivo venous catheter biofilm model46. This was also the case in
a temporal gene expression analysis using in vitro denture and
catheter models47. Interestingly, some pathways such as hexose
transport, amino acid uptake and stress responses that our
differential gene expression analysis predicted to be upregulated
in mature biofilms grown in high CO2 were concluded to be
upregulated only in early-phase biofilms (12 h) in a denture and
catheter study47. The authors concluded that the result of the
induction of these pathways is the increase of intracellular pools of
pyruvate, pentoses and amino acids, preparing for the large
increase in biomass that occurs later in biofilm development47. We
hypothesise that high CO2 may stimulate these pathways and
maintain their activity even in mature biofilms, thus supporting
the increased biomass and maturation rate of biofilms observed
when grown in high CO2.
We observed an increase in azole antifungal resistance within C.
albicans biofilms grown in 5% CO2. This, at least partly, could be
explained by the increased expression of drug transporter genes
such as MDR1, which have previously been implicated in azole
resistance41,48. However, mdr1Δ/Δ, as well as cdr1Δ/Δ and cdr2Δ/Δ,
mutants only exhibit reduced azole resistance in planktonic
culture and early-stage (6 h) biofilms, while levels of resistance are
a b
c
Fig. 9 Efficacy of potential treatments to combat C. albicans biofilms grown in high (5%) CO2. Biofilms were seeded and grown for 48 h
before XTT quantification. a Biofilm growth assay of SN250 in the presence of the Fe3+ chelator Deferasirox. Graph represents two biological
replicates each containing technical triplicates, error bars denote standard deviation. b Biofilm growth assay of SN250 in the presence of the
glycolytic inhibitor 2-DG. Graph represents three biological replicates each containing technical triplicates, error bars denote standard
deviation. Two-way ANOVAs followed by Tukey tests for multiple comparisons were carried out: *p < 0.05, ***p < 0.001. Asterisks directly above
the bars indicate a significant difference to the untreated SN250 in the same CO2 environment. c Representative images of SN250 biofilms
grown in 5% CO2 ± 2-DG for 48 h.
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maintained in mature biofilms41. Therefore, we propose that it is
more likely the increased azole resistance phenotype of 5% CO2
biofilms displayed is contributed to via another mechanism,
possibly increased ECM deposition. β-1,3-Glucan, a major compo-
nent of biofilm ECM, can bind to azole antifungals and sequester
them to prevent passage to the cells49. We have observed that,
after 48 h, 5% CO2 biofilms, while containing similar cell numbers
to 0.03% CO2 biofilms, were significantly thicker. This could
suggest more ECM material being produced in high CO2
environments, contributing to the increased azole resistance.
Furthermore, Miconazole treatment has been shown to generate
superoxide radicals within C. albicans biofilms and leads to the
increased expression of SOD5 and SOD6 (encode superoxide
dismutase enzymes) in an attempt to protect against the toxic
superoxides. A sod4Δ/Δsod5Δ/Δsod6Δ/Δ triple mutant is hyper-
sensitive to Miconazole treatment when growing as a biofilm50.
Our transcriptome analysis revealed that SOD6 and SOD4 were
upregulated in 5% CO2 biofilms, providing a potential further
mechanism for increased Miconazole resistance.
Our study identified that TFs involved in iron homoeostasis are
important for C. albicans biofilm growth. Principal among these
were the Hap TFs, which come together to form the HAP complex,
a CCAAT box-binding transcriptional regulator, under iron-limiting
conditions. Genetic studies have revealed a requirement of HAP2,
HAP3, HAP5 and HAP43 for growth in low-iron media30,51. Thus, the
biofilm formation defect exhibited by the hap2Δ/Δ, hap3Δ/Δ,
hap5Δ/Δ and hap43Δ/Δ mutants in 0.03% CO2 could be explained
by this growth deficiency since RPMI-1640 media has a low-iron
content. Nevertheless, this makes it even more intriguing that
simply an increase in ambient CO2 levels was able to significantly
increase the biofilm growth of these mutants. The HAP complex
represses a GATA-type TF called Sfu1; Sfu1 is responsible for
repressing iron-uptake genes along with SEF1 under iron-replete
conditions. Sef1 activates iron-uptake genes as well as HAP43,
HAP2 and HAP352, in this way the HAP complex is able to induce
iron-uptake pathways while repressing iron-utilisation genes31,52.
Deletion of Sef1 results in the aberrant downregulation of all the
major iron-uptake pathways of C. albicans in low-iron conditions52.
Due to the fact the sef1Δ/Δ and ssn3Δ/Δ mutants had defective
biofilm growth in both CO2 conditions, we hypothesised that a
high CO2 environment may influence one or both of these
directly, causing the HAP complex to become at least partially
redundant under these conditions. We did see a number of genes
involved in iron acquisition had increased transcript levels in 48 h
5% CO2 biofilms. For example, FTR2, which encodes the high-
affinity iron permease Ftr2, had increased expression. In addition,
CFL4, which encodes a putative ferric reductase, is regulated by
Sef1 and induced in low-iron conditions52 was also upregulated.
Finally, the CSA2 and RBT5 genes, which encode proteins involved
in the acquisition of iron from haem groups, were also
upregulated. Csa2 and Rbt5 have both previously been found to
be required for normal biofilm formation in RPMI-1640 media53,54.
The increased Sef1 abundance in mature wild-type biofilms
under high CO2, combined with no such increase in the ssn3 null
mutant, implies that this was an Ssn3-dependent process and
argues against CO2 acting on Sef1 directly. Moreover, Sef1 levels in
the ssn3Δ/Δ background were extremely low in both CO2
environments, consistent with the identical biofilm formation
defect of the sef1Δ/Δ and ssn3Δ/Δ mutants. Conversely, Sef1 levels
were high in the sfu1Δ/Δ background. Given the importance of
Sef1 for biofilm formation on a silicone surface in our assay, this
could explain the significantly increased biofilms formed by the
sfu1Δ/Δ mutant. These cells are likely primed for enhanced iron
acquisition right from the beginning of biofilm growth, increasing
their fitness in this scenario. Ssn3 is a cyclin-dependent kinase and
functions in a post-translational control loop of Sef1 with Sfu132.
We did not observe a significant effect on SEF1mRNA levels within
5% CO2 biofilms after 48 h. Thus, the increase in Sef1 abundance
observed in 5% CO2 biofilms is likely due to CO2 acting at the
post-translational level and our data are consistent with Ssn3
playing a role in this. This is quite surprising since Ssn3 has been
found to be dephosphorylated and hence inactive in planktonic
cells grown in 5% CO255. We see that a correctly functioning iron
homoeostatic network is required for the CO2-mediated increase
in C. albicans attachment to a silicone surface and it has previously
been shown that the adhesin Als3 plays a direct role in iron
acquisition from ferritin56, demonstrating an association between
these processes. It should be noted that, besides their key roles in
iron homoeostasis, the HAP complex and Ssn3 have numerous
and varied tasks throughout the cell31,57. Therefore, although our
data points towards the iron homoeostatic roles being crucial for
C. albicans biofilm growth, other processes cannot be ruled out.
The increased azole resistance of C. albicans biofilms in 5% CO2
along with the observed iron-starvation tolerance when treated
with the Fe3+ chelator Deferasirox has important implications for
the development of potential biofilm treatment strategies. At a
clinical level, this also indicates the location of a C. albicans biofilm
within the body should be taken into consideration when
deciding upon the most effective treatment. Encouragingly,
2-DG was able to attenuate C. albicans biofilm growth in both
Fig. 10 Predicted model of the interplay between CO2 signalling
and iron homoeostasis in C. albicans biofilms on silicone surfaces.
High environmental levels of CO2 drive biofilm formation via the
Ras1-Cyr1-PKA pathway in the same way as previously shown for
hyphal morphogenesis in planktonic cells. This is accompanied by
an increase in iron-scavenging capability by biofilm-associated cells.
Our data are consistent with a CO2-mediated activation of PKA via
Cyr1 resulting in increased abundance and activity of Sef1 in an
Ssn3-dependent manner (this process may also involve the
inhibition of Sfu1). Subsequent increased expression of iron
uptake genes thus enables more effective scavenging of
environmental iron.
D.R. Pentland et al.
11
Published in partnership with Nanyang Technological University npj Biofilms and Microbiomes (2021)    67 
5% and atmospheric (0.03%) CO2 environments. 2-DG has
exhibited antimicrobial effects against fungal moulds58 and
bacterial biofilms59. This, together with its action against C.
albicans biofilms presented here, highlights the potential for 2-DG
to be used an anti-biofilm therapeutic. It may be particularly useful
for medical devices such as VPs, which are situated in CO2-rich
environments in the body and are often colonised by a mixture of
bacterial and fungal species60–63. It is important to note, however,
that 2-DG was unable to eradicate C. albicans biofilm growth
completely. It may be that 2-DG treatment is beneficial in
combination with other compounds, such as iron chelators or
traditional antifungals; this possibility is yet to be explored.
In conclusion, our data demonstrate that elevated levels of CO2
act as an important driver of C. albicans biofilm formation, growth
and maturation. These CO2-mediated effects are not only likely to
have important medical ramifications, particularly in the context of
prosthetics and airway management devices, but also for host
infections in CO2-rich environments in the body.
METHODS
Candida strains and growth media
Candida strains (Supplementary Table S1) were routinely grown at 30 °C in
yeast peptone dextrose (YPD) media (2% peptone (BD Bacto), 2% D-
glucose (Fisher Scientific), 1% yeast extract (BD Bacto)). For biofilm growth
assays, Candida biofilms were grown at 37 °C in RPMI-1640 media (Sigma-
Aldrich, R8755) supplemented with 80 µg/ml uridine (Sigma-Aldrich,
U3750) if required. The C. albicans TFKO library we used was generated
by Homann et al. as described in ref. 30. Briefly, deletions were constructed
using auxotrophic marker cassettes targeted with long-flanking homology.
C. albicans strain SN152 (arg4Δ/Δ, leu2Δ/Δ, his1Δ/Δ, URA3/ura3Δ, IRO1/
iro1Δ) was transformed with C. maltosa LEU2 and Candida dubliniensis HIS1,
which integrated at the targeted transcriptional regulator locus, deleting
both alleles. A ‘wild-type’ control strain (SN250) was created by the
reintroduction of single alleles of C. dubliniensis HIS1 and Candida maltosa
LEU2 into SN15230. The ssn3Δ/Δ null mutant was constructed using the
same method64. The CDH107 (ras1Δ/Δ), CR276 (cdc35Δ/Δ) and WYF2
(CDC35ΔRA) strains were constructed as described in refs. 65–67, respectively.
In vitro biofilm growth assays
C. albicans biofilms were grown on a polydimethylsiloxane (PDMS) silicone
elastomer (Provincial Rubber, S1). The silicone was cut into 1 cm2 squares
and placed in clips in a modified 24-well plate lid (Academic Centre for
Dentistry Amsterdam, AAA-model) so they could be suspended in media
within a 24-well plate. Silicone squares were incubated in 1ml 50% Donor
Bovine Serum (DBS; Gibco, 16030074) for 30min at 30 °C, then washed
twice with 1ml phosphate-buffered saline (PBS) to remove excess DBS. In
all, 1 ml of C. albicans were added to each well of a 24 well plate (Greiner
Bio-one, CELLSTAR, 662160) following resuspension in PBS at an OD600 of
1.0 and the lid with the silicone squares attached was placed on top so the
silicone squares protrude into the cell suspension. Plates were then
incubated at 37 °C (in either 0.03% CO2 or 5% CO2) without shaking for
90min to allow cell attachment to the silicone. After the attachment phase,
the silicone squares were washed twice with 1ml PBS to remove any
unattached cells and transferred to 1ml RPMI-1640 media (Sigma-Aldrich,
R8755). They were then incubated at 37 °C (in either 0.03% CO2 or 5% CO2)
without shaking for 48 h to allow biofilm maturation.
Biofilm quantification via XTT assay
Biofilm growth was quantified using an XTT assay29. Biofilms were washed
twice with 1 ml PBS to remove any planktonic cells before proceeding to
quantification. After washing, the biofilms were transferred to a new pre-
sterilised 24-well plate containing 30 µg/ml XTT labelling reagent (Roche,
11465015001) and incubated at 37 °C for 4 h. After incubation, the biofilms
were removed from the 24-well plate and the absorbance of the remaining
XTT labelling reagent was measured at 492 nm using a BMG LABTECH
FLUOstar Omega plate reader.
Biofilm quantification via dry biomass assay
Biofilms were set up and grown on a 30 cm2 square of PDMS silicone
elastomer (Provincial Rubber, S1), which was attached to the base of a petri
dish. Silicone squares were incubated in 30ml 50% DBS for 30min at 30 °C,
then washed with 30ml PBS to remove excess DBS. In all, 30 ml C. albicans
were added to each petri dish following resuspension in PBS at an OD600 of
0.1. Plates were then incubated at 37 °C (in either 0.03% CO2 or 5% CO2)
without shaking for 90min to allow cell attachment to the silicone. After
the attachment phase, the silicone squares were washed with PBS to
remove any unattached cells, then bathed in 30ml RPMI-1640 media. They
were then incubated at 37 °C (in either 0.03% CO2 or 5% CO2) without
shaking for 24 or 48 h to allow biofilm maturation. Following maturation,
biofilms were washed with PBS to remove any planktonic cells and
harvested using 2 cm blade cell scrapers (Jet Biofil, CSC011025) to scrape
adhered biofilms into PBS. The resultant biofilm suspension was collected
and passed through a pre-weighed 47mm diameter 0.45 µm nitrocellulose
membrane filter (Whatman, 7184 004) by vacuum filtration. The
membranes were allowed to air dry and weighed on a 0.1 mg
microbalance (Ohaus Explorer Pro, EP64C).
C. albicans TFKO screen
C. albicans mutants from a TFKO library were screened for biofilm-forming
ability in both 0.03 and 5% CO2. Biofilms were seeded and grown for 48 h
on a PDMS silicone elastomer (Provincial Rubber, S1) as described above.
Biofilm growth was quantified using the XTT assay. Experiments were
performed in biological triplicate.
Iron starvation of C. albicans biofilms
Biofilms were set up as described in the ‘In vitro biofilm growth assay’
section above except they were incubated at 37 °C in either 0.03% CO2 or
5% CO2 for 48 h in RPMI-1640 containing varying concentrations of the
Fe2+ chelator 3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p’-disulfonic acid
monosodium salt hydrate (Ferrozine—Sigma-Aldrich, 160601) or the Fe3+
chelator Deferasirox (Cambridge Bioscience, CAY16753-5). Ferrozine was
made as a 100mM stock solution in sterile MQ H2O and diluted in RPMI-
1640 to final concentrations of 250–500 μM. Deferasirox was made as a
20mg/ml stock solution in dimethyl sulfoxide (DMSO) and diluted in RPMI-
1640 to final concentrations of 70–210 µg/ml. Relevant solvent controls
were included. Final biofilms were quantified using an XTT assay.
Preparation of PDMS-coated microscope slides
To prepare PDMS for coating microscope slides 16 g (6.16 × 10−4 mol)
silanol-terminated PDMS (cSt 1000, MW 26000, from Fluorochem Ltd.) and
0.26 g (1.248mmol, 1:4 stoichiometric ratio) cross-linking agent tetraethyl
orthosilicate (Sigma-Aldrich, 131903) were mixed at 3500 r.p.m. for 1 min
using a DAC 150FV2-K speedmixer. At this point, 720 µl tin(II) ethylhex-
anoate (Sigma-Aldrich, S3252) made up at a concentration of 0.6 M in
toluene was added as a catalyst and the mix spun for a further 60 s at
3500 r.p.m. The elastomer mixture was then doctor bladed onto
microscope slides using an automatic precision film applicator MTCX4
(Mtv-Messtechnik—blade width= 70mm, thickness adjustability
0–3000 µm). The doctor blade height was set 10 µm higher than the
thickness of the microscope slide. The elastomer mix was poured over the
top of the slide (with a bias towards the side of the microscope slide
closest to the doctor blade), and then the doctor blade is moved at a
constant speed over the substrate. The microscope slide was then air cured
for 2 h before being heat cured for 18 h in a 70 °C oven.
Preparation of C. albicans biofilms on silicone-coated slides for
microscopy
Biofilms were grown directly on microscope slides that had been
precoated with a PDMS silicone polymer (see above) for confocal imaging.
Biofilms were grown with a prefabricated well. PDMS-coated microscope
slides were incubated with 400 µl 50% DBS (Gibco, 16030074) in the wells
for 30min at 30 °C and washed twice with 400 µl PBS. C. albicans overnight
cultures were grown in YPD at 30 °C and washed twice in PBS. In all, 400 µl
of the OD600 1.0 standard cell suspension was added to the wells and
incubated at 37 °C (in either 0.03% CO2 or 5% CO2) without shaking for
90min to allow cell attachment to the silicone surface. After attachment,
the microscope slides were washed twice with 400 µl PBS to remove any
unattached cells and then incubated at 37 °C with 400 µl RPMI-1640 media
in the wells for 6, 24 or 48 h (in either 0.03% CO2 or 5% CO2). Biofilms were
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washed twice with 400 µl PBS and then incubated in the dark for 45min at
30 °C in 400 µl PBS containing 50 µg/ml ConA-FITC (Sigma-Aldrich, C7642)
and 20 µM FUN-1 (Invitrogen Molecular Probes, F7030). After incubation
with the dyes, the stained biofilms were washed again with 400 µl PBS to
remove any residual dye. The well was removed and two drops of
ProLongTM Diamond Antifade Mountant (Invitrogen, P36965) was added to
each stained biofilm. A cover slip was placed on top and the microscope
slides were incubated in the dark at room temperature overnight to allow
the mountant to cure.
Preparation of C. albicans biofilms on chamber slides for
microscopy
Biofilms were grown within Ibidi µ-slide eight-well microscope slides with
polymer coverslip bottom (Ibidi, 80821) following the procedure described
above with some alterations. Specifically, DBS was not used as the
chamber slides had been precoated with poly-L-lysine to aid attachment.
These biofilms were stained with 400 µl FilmTracer SPYRO Ruby biofilm
matrix stain (Invitrogen Molecular Probes, F10318). Coverslips were not
added as the bottom of the chamber slide is a coverslip.
CSLM of C. albicans biofilms
Stained biofilms grown on silicone-coated slides or Ibidi chamber slides
were imaged using a Zeiss LSM880/Elyra/Axio Observer.Z1 Confocal
Microscope (Carl Zeiss Inc.) using the 488 nm argon and the 561 nm
DP55 lasers. Images of the green (ConA-FITC) and the red (FUN-1)
fluorescence were taken simultaneously using a multitrack mode. Images
of the SPYRO Ruby biofilm matrix stain were taken individually using a
single track. Z-stacks were taken using the inbuilt ‘optimal’ settings to
determine the optimal intervals (typically 1.5–2.0 µm slices) based on
sample thickness and magnification. The ×20 and oil-immersion ×40
objective lenses were used throughout. The image acquisition software
used was ZENBlack and the image processing software was ZENBlue.
RNA isolation from C. albicans biofilms
Total RNA was extracted in biological triplicate per condition (0.03% and
5% CO2) using the E.Z.N.A.TM Yeast RNA Kit (Omega Bio-Tek, R6870-01) as
per the manufacturer’s instructions with a few modifications. Specifically, C.
albicans CAI-4 biofilms were seeded and grown in 0.03 and 5% CO2 as
described for in vitro biofilm growth assays. Mature biofilms were washed
twice with 1 ml ice-cold PBS to remove any planktonic cells. Biofilm cells
were harvested by transferring silicone squares upon which the biofilms
were growing into 5ml cold SE buffer/2-mercaptoethanol (provided in the
E.Z.N.A.TM Yeast RNA Kit) and vortexing at 2500 r.p.m. for 1 min. The
resulting biofilm cell suspension was pelleted by centrifugation at 4000 r.p.
m. for 10min at 4 °C. The supernatant was discarded and the cells were re-
suspended in fresh 1ml cold SE buffer/2-mercaptoethanol; this cell
suspension was transferred to a 2ml Eppendorf tube. The cell suspension
was centrifuged again for 10min at 4 °C, the supernatant was discarded
and the pellet was re-suspended in 480 µl fresh SE buffer/2-mercaptoetha-
nol. The biofilm cell suspension was incubated with 80 µl lyticase stock
solution (5000 units/ml in SE buffer) at 30 °C for 90min. The resulting
spheroplasts were pelleted by centrifugation at 2900 r.p.m. for 10min at
4 °C and the supernatant was aspirated and discarded. The spheroplasts
were gently re-suspended in 350 µl YRL buffer/2-mercaptoethanol
(provided in the E.Z.N.A.TM Yeast RNA Kit). The rest of the RNA extraction
proceeded as per the manufacturer’s instructions including the optional
DNase digestion step. RNA was eluted in 30 µl DEPC water; the
concentration and purity established using a NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies) and stored at −80 °C.
Library preparation and RNA sequencing
RNA samples were sent to the Centre for Genome Enabled Biology and
Medicine (Aberdeen, UK) for library preparation and sequencing. Before
library preparation, the quality and quantification of RNA samples were
evaluated with TapeStation (Agilent) and Qubit (Thermal Fisher). Samples
with a minimum RNA Integrity Number of 8.0 proceeded to library
preparation. The input of RNA was based on the specifically measured RNA
concentration by Qubit. The mRNA-Seq libraries were prepared using the
TruSeq™ Stranded mRNA Sample Preparation Kit (Illumina) according to
the manufacturer’s instructions. Briefly, Poly-A RNA were purified from
500 ng of total RNA with 1 µl (1:100) ERCC spike (Thermal Fisher) as an
internal control using RNA purification oligo(dT) beads, fragmented and
retrotranscribed using random primers. Complementary DNAs were end-
repaired, and 3-adenylated, indexed adaptors were then ligated. Fifteen
cycles of PCR amplification were performed, and the PCR products were
cleaned up with AMPure beads (Beckman Coulter). Libraries were validated
for quality on the Agilent DNA1000 Kit and quantified with the qPCR NGS
Library Quantification Kit (Roche). The final libraries were equimolar pooled
and sequenced using the High Output 1×75 Kit on the Illumina
NextSeq500 platform producing 75 bp single-end reads. For each library,
a depth of 50–70M reads was generated.
Analysis of RNA-Seq data
Analysis of RNA-Seq data was performed using the Galaxy web platform68.
The quality of the RNA sequencing reads was checked using FastQC
v0.11.569 with default settings. Low-quality ends (Phred score <20) and any
adaptor sequences were trimmed using TrimGalore! v0.4.370. Reads that
became <40 bp after trimming were removed from further analysis. After
trimming, 97.7% of initial reads remained and the quality was checked
again using FastQC v0.11.569. There were no Poly-A reads (>90% of the
bases equal A), ambiguous reads (containing N) or low-quality reads (>50%
of the bases with a Phred score <25). After processing, the mean Phred
score per read was 35. Processed reads were aligned with the reference C.
albicans genome SC5314 version A21-s02-m09-r10 using HISAT2 v2.1.071
with single-end reads and reverse strand settings (rest of the settings were
default). After alignment, the number of mapped reads that overlapped
CDS features in the genome (using the C. albicans_SC5314_version_A21-
s02-m09-r10_features.gtf annotation file72) were determined using htseq-
count v0.9.173 with default settings. Reads aligning to multiple positions or
overlapping more than one gene were discarded, counting only reads
mapping unambiguously to a single gene. Differential gene expression
analysis between conditions (0.03 and 5% CO2) was performed using
DESeq2 v1.18.174 with default settings. Raw and normalised data files were
deposited with the Gene Expression Omnibus repository (GSE172004).
GSEA of transcription profiles
Downstream analysis of RNA-Seq data was performed using the PreRanked
tool of GSEA (Broad Institute)33, which compares a pre-ranked significantly
differentially expressed gene list to a functional gene set database. FDR q
values were calculated based on 1000 permutations. The gene set
database used was assembled by Sellam et al. as described in ref. 75, which
is based on experimental analyses from published studies, GO term
categories curated by the Candida Genome Database76 and
protein–protein interaction information derived from Saccharomyces
cerevisiae data curated by the Saccharomyces Genome Database77. Gene
set networks were generated in Cytoscape 3.7.1 (Available at: https://
cytoscape.org/)34 using the EnrichmentMap plug-in (available at http://
apps.cytoscape.org/apps/enrichmentmap). Gene expression heat maps
based on GO term categories were created using the Pheatmap package in
R Studio.
Antifungal treatment of C. albicans biofilms
Biofilms were set up as described in the ‘In vitro biofilm growth assay’
section above and grown in RPMI-1640 for 24 h at 37 °C. The biofilms were
then transferred to fresh RPMI-1640 media containing a select antifungal.
Four antifungals were tested; Fluconazole, Miconazole, Nystatin, and
Caspofungin. Fluconazole (Santa Cruz Biotechnology, sc-205698) was
made as a 50mg/ml stock solution in ethanol and diluted in RPMI-1640 to
final concentrations ranging from 8 to 256 µg/ml. Miconazole (Santa Cruz
Biotechnology, sc-205753) was made as a 50mg/ml stock solution in
DMSO and also diluted in RPMI-1640 to final concentrations ranging from 8
to 256 µg/ml. Nystatin (Santa Cruz Biotechnology, sc-212431) was made as
a 5mg/ml stock solution in DMSO and diluted in RPMI-1640 to final
concentrations ranging from 1 to 8 µg/ml. Caspofungin (Sigma SML0425)
was made as a 16mg/ml stock solution in DMSO and diluted in RPMI-1640
to final concentrations ranging from 0.03125 to 1 µg/ml. Drug vehicle
controls (0.5% ethanol for Fluconazole, 0.5% DMSO for Miconazole and
Nystatin, 0.1% DMSO for Caspofungin) were used in all cases. The biofilms
matured in the RPMI-1640 media containing the select antifungal for a
further 24 h at 37 °C in both 0.03 and 5% CO2 before proceeding to
quantification via the XTT assay. Experiments were performed in biological
and technical triplicate.
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C. albicans attachment assay
CAI-4 cells were seeded onto silicone-coated microscope slide for 90min at
an OD600 of 0.1 without DBS pre-treatment. The slide surface was washed
twice with 400 µl PBS to remove any unattached cells. Images were taken
using a Leica DMR fitted with a Leica DFC9000 GT camera using a ×20
objective lens and brightfield settings. The image acquisition software
used was the Leica Application Suite X package. Using identical
microscope settings throughout, five images were taken of each of three
biological replicates in both 0.03 and 5% CO2, and the cells per image were
counted using the ‘Cell Counter’ function in ImageJ.
2-DG treatment of C. albicans biofilms
Biofilms were set up as described in the ‘In vitro biofilm growth assay’
section above except that they were incubated at 37 °C in either 0.03% CO2
or 5% CO2 for 48 h in RPMI-1640 containing varying concentrations of
2-DG. 2-DG (Sigma-Aldrich, D6134) was made up as a 20% stock solution in
sterile MQ H2O and diluted in RPMI-1640 to final concentrations of
0.25–1%. Biofilms were quantified using XTT assays and images were also
taken. Experiments were performed in biological and technical triplicate.
C. albicans biofilm dispersion assay
Biofilms were set up as described in the ‘In vitro biofilm growth assay’
section above and grown in RPMI-1640 for 48 h at 37 °C. The spent media,
containing dispersed cells, was sonicated at amplitude 4 µm for 10 s to
separate clumps of hyphal cells (previous work in our laboratory has
demonstrated that these sonication settings do not affect viability). After
sonication, the dispersed cells were diluted 1 in 10 and 200 µl of this
suspension was plated on YPD agar plates in triplicate. YPD plates were
incubated for 48 h at 37 °C to allow colonies to form, at which point the
number of colonies were manually counted using a Stuart Scientific Colony
Counter. Experiments were performed in biological and technical triplicate.
Cell wall stress sensitivity spotting assay
CAI4 cells were grown overnight in 5ml YPD, then diluted to an OD600 of 1.
A dilution series was created (100, 10−1, 10−2, 10−3, 10−4, 10−5) and
spotted onto YPD agar plates containing 50 µg/ml Congo Red (Sigma-
Aldrich, C6277) and YPD agar plates containing 25 µg/ml Calcofluor White
(Sigma-Aldrich, 18909). The plates were incubated for 48 h at 30 °C.
Cell wall stress sensitivity planktonic growth assay
CAI4 cells were grown overnight in 5 ml YPD, then diluted to an OD600 of
0.1 in YPD containing increasing concentrations of Congo Red (3.125-
50 µg/ml) or Calcofluor White (1.5625-25 µg/ml) in a 96-well plate (Greiner
Bio-one, CELLSTAR, 655180). The plates were incubated with 400 r.p.m.
double orbital shaking in a BMG LABTECH SPECTROstarNano plate reader for
48 h at 37 °C in both 0.03 and 5% CO2. Growth was measured by OD600
readings taken every 10min. The lag times and growth rates for each
condition were calculated by fitting the growth curves to a Baranyi model
using the DMFit software.
Protein extraction from C. albicans biofilms
Biofilms were seeded on the bottom of wells in a 6-well plate (Greiner Bio-
one, CELLSTAR, 657160) and grown in RPMI-1640 for 48 h at 37 °C. Mature
biofilms were washed twice with 1ml ice-cold PBS to remove any
planktonic cells. In all, 1 ml ice-cold lysis buffer (100mM sodium phosphate
buffer pH 7.8, 5 mM EDTA, 0.1% Triton, 50 mM NaCl, Pierce protease and
phosphatase inhibitor (Thermo Scientific, A32961)) was added to each well
and biofilm cells were scraped from the bottom of the wells. Three biofilms
worth of material per strain and condition were combined and centrifuged
at 4000 rpm for 5min at 4 °C. The supernatant was discarded and biofilm
cells resuspended in 500 µl lysis buffer. This cell suspension was added to a
pestle and mortar on dry ice and frozen with liquid nitrogen; cells were
mechanically lysed by grinding. Cell lysates were collected and centrifuged
at 14,000 r.p.m. for 5 min at 4 °C. Protein concentration of the supernatants
was measured by the Bradford assay. Proteins were concentrated by
trichloroacetic acid precipitation.
Immunoblotting
Protein extracts (10 µg total protein per sample) were analysed by sodium
dodecyl sulphate–polyacrylamide gel electrophoresis (Wako, SuperSep Ace
199-14971) and immunoblotted with a 9E10 anti-c-myc antibody (Sigma-
Aldrich, M4439) for Myc-tagged Sef1. Immunoblots were also probed with
an anti-PGK1 antibody (M. F. Tuite laboratory) as a loading control. All
western blots derive from the same experiment and were processed in
parallel.
Statistical analyses
Statistically significant differences between dependent variables were
assessed with either a paired two-tailed t test or, more often, with a two-
way analysis of variance followed by Tukey test for multiple comparisons.
All statistical analyses were carried out using GraphPad Prism, version 9.0.2.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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